Company intelligence / Profile preview

Pan Pharmaceuticals

Sydney, New South Wales, Australiatga.gov.au ↗

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Pan Pharmaceuticals was once Australia's largest contract manufacturer of medicinal products, specializing in complementary medicines such as herbal and vitamin supplements. In 2003, its manufacturing license was suspended after major regulatory breaches were discovered by the Therapeutic Goods Administration (TGA), leading to one of the largest product recalls in Australian history. The company entered liquidation and ceased operations as an independent entity.

Therapeutic areas: NeurologyOther
Modalities: Small moleculeHerbal productVitamin/mineral supplement
Industry: Contract Manufacturing Organization

Partnerships

No major pharmaceutical or biotech partnerships are documented; business model focused on contract manufacturing for various clients.

Beyond the preview

Go deeper on Pan Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pan Pharmaceuticals.

Explore the full profile